Skip to main navigation Skip to search Skip to main content

Assessing the genetic architecture of epithelial ovarian cancer histological subtypes

  • Gabriel Cuellar-Partida
  • , Yi Lu
  • , Suzanne C. Dixon
  • , Ovarian Cancer Study Australian Ovarian Cancer Study
  • , Peter A. Fasching
  • , Alexander Hein
  • , Stefanie Burghaus
  • , Matthias W. Beckmann
  • , Diether Lambrechts
  • , Els Van Nieuwenhuysen
  • , Ignace Vergote
  • , Adriaan Vanderstichele
  • , Jennifer Anne Doherty
  • , Mary Anne Rossing
  • , Jenny Chang-Claude
  • , Anja Rudolph
  • , Shan Wang-Gohrke
  • , Marc T. Goodman
  • , Natalia Bogdanova
  • , Thilo Dörk
  • Matthias Dürst, Peter Hillemanns, Ingo B. Runnebaum, Natalia Antonenkova, Ralf Butzow, Arto Leminen, Heli Nevanlinna, Liisa M. Pelttari, Robert P. Edwards, Joseph L. Kelley, Francesmary Modugno, Kirsten B. Moysich, Roberta B. Ness, Rikki Cannioto, Estrid Høgdall, Claus Høgdall, Allan Jensen, Graham G. Giles, Fiona Bruinsma, Susanne K. Kjaer, Michelle A.T. Hildebrandt, Dong Liang, Karen H. Lu, Xifeng Wu, Maria Bisogna, Fanny Dao, Douglas A. Levine, Daniel W. Cramer, Kathryn L. Terry, Shelley S. Tworoger, Meir Stampfer, Stacey Missmer, Line Bjorge, Helga B. Salvesen, Reidun K. Kopperud, Katharina Bischof, Katja K.H. Aben, Lambertus A. Kiemeney, Leon F.A.G. Massuger, Angela Brooks-Wilson, Sara H. Olson, Valerie McGuire, Joseph H. Rothstein, Weiva Sieh, Alice S. Whittemore, Linda S. Cook, Nhu D. Le, C. Blake Gilks, Jacek Gronwald, Anna Jakubowska, Jan Lubiński, Tomasz Kluz, Honglin Song, Jonathan P. Tyrer, Nicolas Wentzensen, Louise Brinton, Britton Trabert, Jolanta Lissowska, John R. McLaughlin, Steven A. Narod, Catherine Phelan, Hoda Anton-Culver, Argyrios Ziogas, Diana Eccles, Ian Campbell, Simon A. Gayther, Aleksandra Gentry-Maharaj, Usha Menon, Susan J. Ramus, Anna H. Wu, Agnieszka Dansonka-Mieszkowska, Jolanta Kupryjanczyk, Agnieszka Timorek, Lukasz Szafron, Julie M. Cunningham, Brooke L. Fridley, Stacey J. Winham, Elisa V. Bandera, Elizabeth M. Poole, Terry K. Morgan, Ellen L. Goode, Joellen M. Schildkraut, Celeste L. Pearce, Andrew Berchuck, Paul D.P. Pharoah, Penelope M. Webb, Georgia Chenevix-Trench, Harvey A. Risch, Stuart MacGregor
  • Queensland Institute of Medical Research
  • University of Queensland
  • Peter Maccallum Cancer Centre
  • University of California at Los Angeles
  • Friedrich-Alexander University Erlangen-Nürnberg
  • KU Leuven
  • Flanders Institute for Biotechnology
  • Dartmouth College
  • University of Washington
  • Fred Hutchinson Cancer Research Center
  • German Cancer Research Center
  • University of Hamburg
  • Ulm University
  • Cedars-Sinai Medical Center
  • Hannover Medical School
  • Friedrich Schiller University Jena
  • N.N. Alexandrov National Cancer Centre of Belarus
  • Helsinki University Hospital
  • University of Pittsburgh
  • University of Texas Health Science Center at Houston
  • Roswell Park Cancer Institute
  • Danish Cancer Society
  • University of Copenhagen
  • Monash University
  • University of Melbourne
  • Cancer Council Victoria
  • University of Texas MD Anderson Cancer Center
  • Texas Southern University
  • Memorial Sloan-Kettering Cancer Center
  • Brigham and Women’s Hospital
  • Harvard University
  • University of Bergen
  • Radboud University Nijmegen
  • Netherlands Comprehensive Cancer Organisation
  • Provincial Health Services Authority
  • Simon Fraser University
  • Stanford University
  • University of New Mexico
  • University of British Columbia
  • Pomeranian Medical University in Szczecin
  • University of Rzeszów
  • University of Cambridge
  • National Institutes of Health
  • Maria Sklodowska-Curie Institute of Oncology
  • Public Health Ontario
  • University of Toronto
  • Moffitt Cancer Center
  • University of California at Irvine
  • University of Southampton
  • University of Southern California
  • University College London
  • Medical University of Warsaw
  • Mayo Clinic Rochester, MN
  • University of Kansas
  • Rutgers - The State University of New Jersey, New Brunswick
  • Oregon Health and Science University
  • University of Virginia
  • University of Michigan, Ann Arbor
  • Duke University
  • Yale University

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Epithelial ovarian cancer (EOC) is one of the deadliest common cancers. The five most common types of disease are high-grade and low-grade serous, endometrioid, mucinous and clear cell carcinoma. Each of these subtypes present distinct molecular pathogeneses and sensitivities to treatments. Recent studies show that certain genetic variants confer susceptibility to all subtypes while other variants are subtype-specific. Here, we perform an extensive analysis of the genetic architecture of EOC subtypes. To this end, we used data of 10,014 invasive EOC patients and 21,233 controls from the Ovarian Cancer Association Consortium genotyped in the iCOGS array (211,155 SNPs). We estimate the array heritability (attributable to variants tagged on arrays) of each subtype and their genetic correlations. We also look for genetic overlaps with factors such as obesity, smoking behaviors, diabetes, age at menarche and height. We estimated the array heritabilities of high-grade serous disease (hg2 = 8.8 ± 1.1 %), endometrioid (hg2 = 3.2 ± 1.6 %), clear cell (hg2 = 6.7 ± 3.3 %) and all EOC (hg2 = 5.6 ± 0.6 %). Known associated loci contributed approximately 40 % of the total array heritability for each subtype. The contribution of each chromosome to the total heritability was not proportional to chromosome size. Through bivariate and cross-trait LD score regression, we found evidence of shared genetic backgrounds between the three high-grade subtypes: serous, endometrioid and undifferentiated. Finally, we found significant genetic correlations of all EOC with diabetes and obesity using a polygenic prediction approach.

Original languageEnglish
Pages (from-to)741-756
Number of pages16
JournalHuman Genetics
Volume135
Issue number7
DOIs
StatePublished - Jul 1 2016

Fingerprint

Dive into the research topics of 'Assessing the genetic architecture of epithelial ovarian cancer histological subtypes'. Together they form a unique fingerprint.

Cite this